Cytokine-induced killer cell
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immune response
lymphocyte |
| gptkbp:activatedBy |
gptkb:anti-CD3_antibody
gptkb:interferon-gamma gptkb:interleukin-2 cytokines |
| gptkbp:advantage |
broad antitumor activity
non-MHC restricted cytotoxicity rapid expansion in vitro |
| gptkbp:alsoKnownAs |
gptkb:CIK_cell
|
| gptkbp:cytotoxicTo |
tumor cells
virus-infected cells |
| gptkbp:derivedFrom |
gptkb:natural_killer_cells
gptkb:T_cells |
| gptkbp:discoveredIn |
1991
|
| gptkbp:expressedIn |
gptkb:CD56
gptkb:NKG2D gptkb:CD3 gptkb:CD8 |
| gptkbp:function |
immunotherapy
tumor cell killing |
| https://www.w3.org/2000/01/rdf-schema#label |
Cytokine-induced killer cell
|
| gptkbp:originatedIn |
peripheral blood mononuclear cells
|
| gptkbp:studiedIn |
clinical trials
|
| gptkbp:usedIn |
gptkb:cancer
adoptive cell therapy |
| gptkbp:bfsParent |
gptkb:CCK
|
| gptkbp:bfsLayer |
5
|